Restoring white matter to improve cognitive function in vascular dementia
White Matter Restoration in Vascular Cognitive Impairment and dementia
This study is exploring a new way to help improve thinking and memory in people with vascular cognitive impairment and dementia by trying to repair damaged brain tissue, and it's being tested in mice to see how well it works.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10609966 on NIH RePORTER |
What this research studies
This research investigates how to restore white matter in the brain to help improve cognitive function in patients with vascular cognitive impairment and dementia. The approach involves reprogramming certain brain cells called astrocytes into oligodendrocyte progenitor cells, which can then develop into mature oligodendrocytes that repair white matter injury. By using mouse models that simulate conditions of reduced blood flow to the brain, the researchers aim to understand how these reprogrammed cells can enhance cognitive recovery and overall brain health. This innovative method could lead to new therapies for patients suffering from this type of dementia.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with vascular cognitive impairment or dementia, particularly those experiencing cognitive decline related to reduced blood flow to the brain.
Not a fit: Patients with dementia not related to vascular issues, such as Alzheimer's disease, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve cognitive function and quality of life for patients with vascular cognitive impairment and dementia.
How similar studies have performed: While the approach of reprogramming astrocytes into oligodendrocytes is innovative, similar strategies targeting white matter restoration have shown promise in preliminary studies.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Cao, Guodong — University of Pittsburgh at Pittsburgh
- Study coordinator: Cao, Guodong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.